Sugi Holdings Co.,Ltd.

7649.T
Pharmaceutical Retailers
2026/02/17 Updated
Market Cap: $4.3B (¥658.0B)
Stock Price: $23.67 (¥3,636)
Exchange Rate: 1 USD = ¥153.61

Notice Regarding Executive Officers

Sugi Holdings Co., Ltd. will change its executive officer structure effective March 1, 2026, appointing multiple executive officers including three new members.

Importance:
Page Updated: January 26, 2026
IR Disclosure Date: January 26, 2026

Key Figures

  • Number of Newly Appointed Executive Officers: 3
  • Date of Executive Officer Structure Change: Effective March 1, 2026
  • Date of Board Resolution: January 26, 2026

AI要約

Details of Changes to the Executive Officer Structure

At the board meeting held on January 26, 2026, Sugi Holdings Co., Ltd. resolved to appoint executive officers effective March 1, 2026. The three newly appointed executive officers include Mari Konagaya, General Manager of the Legal Department; Kenta Morii, in charge of International Business (Planning and Promotion); and Toshihiko Asaka, responsible for Dispensing. Existing executive officers, including Makoto Kasai who serves as Chief Financial Officer and is in charge of Corporate Strategy and Finance & Accounting, will continue their respective roles.

Impact on Investors and Future Outlook

The refreshment of the executive officer structure aims to strengthen management strategy, promote international business, and enhance expertise in legal and dispensing fields. Although there is no specific mention of direct impact on financial performance in the document, strengthening the management structure may contribute to enhancing corporate value in the medium to long term. Investors should monitor future management policies and business trends closely.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.